Article
Optimal management of severe symptomatic gastroesophageal reflux disease.
Journal of internal medicine - 1 Feb 2021
Talley N J, Zand Irani M
Abstract excerpt
Gastroesophageal reflux disease (GERD) is a common disorder, and empirical proton pump inhibitor (PPI) treatment is often the first step of management; however, up to 40% of patients remain symptomatic despite PPI treatment. Refractory reflux refers to continued symptoms despite an adequate trial of PPI, and management remains challenging. The differential diagnosis is important; other oesophageal (e.g....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
